Skip to content
Unrated Drug recall · FDA · Published October 31, 2025

Globe Zinc Oxide Ointment Recall: cGMP Deviations

Blossom Pharmaceuticals recalls Globe Zinc Oxide Ointment distributed by Trifecta due to cGMP deviations. Check lot numbers A502404, A502405, AS02502.

🇺🇸 FDA recall #D-0212-2026DrugGlobe ›
Take action

Contact the company

Recalling firmBlossom PharmaceuticalsPlot No. 21/22 Bardez Blossom Pharmaceuticals Karaswada-Tivim · Bardej, Goa, India
✎ GovInfoNow plain-language explainer

Blossom Pharmaceuticals is recalling Globe Zinc Oxide Ointment USP (Zinc Oxide 20% Skin Protectant) because of current Good Manufacturing Practice (cGMP) deviations. The product was distributed nationwide by Trifecta Pharmaceuticals USA. The specific nature of the manufacturing deviations and any resulting health risks are not detailed in the record. Read more at govinfonow.com/recall/31645-globe-zinc-oxide-ointment-recall-cgmp-deviations.

Source Summary by GovInfoNow · govinfonow.com/recall/31645-globe-zinc-oxide-ointment-recall-cgmp-deviations · Updated October 9, 2026 · FDA enforcement record: FDA #D-0212-2026

Cite this page

“Globe Zinc Oxide Ointment Recall: cGMP Deviations.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31645-globe-zinc-oxide-ointment-recall-cgmp-deviations. Based on FDA recall #D-0212-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0212-2026%22&limit=1).

The FDA announced on Oct. 31, 2025, that Blossom Pharmaceuticals is recalling Globe Zinc Oxide Ointment USP due to current good manufacturing practice (cGMP) deviations. The voluntary Class II recall affects 33,000 containers distributed nationwide.

How to tell if you have it

  • Brand: Globe
  • Product: Zinc Oxide Ointment USP
  • NDC: 69396-086-02
  • Lot #: A502404, Exp. Date 2/27
  • Lot #: A502405, Exp. Date 2/27
  • Lot #: AS02502, Exp. Date 2/28

The hazard

The recall is due to cGMP deviations. According to FDA's FAERS database, there are 1,944 adverse-event reports naming this product, including 1,654 marked serious and 204 listing a death; these are unverified reports not findings about this specific recall.

Context

GovInfoNow's records show other recent recalls of similar products include Wells Pharma Fentanyl Citrate Injectable Solution Recall due to CGMP deviations on April 1, 2026, and Ajanta Pharma Fenofibrate Capsules Recall due to CGMP deviations risk on May 28, 2026.

How to tell if you have this one

Check your tube for the brand 'Globe' and the description 'Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant'. Verify the Net Wt. is 2 oz (56.7 g) and the NDC is 69396-086-02. Look for one of these Lot numbers on the packaging: A502404, A502405, or AS02502.

  • Brand
    Globe
  • Category
    Drug
FDA recall event · 13 products

All 13 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    USA Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-0201-2026Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.; Lot #: A162301, Exp. Date 9/26; A162401, Exp. Date 4/27 & A162202, Exp. Date 11/25.9600 containers—
D-0202-2026Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA, Made in India, NDC 67777-407-04.; Lot #: A092334, Exp. Date 6/26 & A092421, Exp. Date 7/271560 containers67777-407-01, 67777-407-02, 67777-407-03, 67777-407-10, 67777-407-04, 67777-407-11, 67777-407-12, 67777-407-13
D-0203-2026Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation, MIddletown, NY 10941 USA, Made in India, NDC 67777-402-01.; Lot #: A022310, Exp. Date 2/26; A022335, Exp. Date 10/26; A022406, Exp Date 12/27 & A022505, Exp Date 12/2718912 containers67777-402-01, 67777-402-02
D-0204-2026Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016.; Lot #: A322301, Exp. Date 7/26 & A322302, Exp. Date 8/268184 bottles—
D-0205-2026WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05.; Lot #: A062434, Exp. Date 6/27 & A062449, Exp. Date 7/272592 bottles67777-223-01, 67777-223-11, 67777-223-02, 67777-223-03, 67777-223-13, 67777-223-04, 67777-223-05, 67777-223-06
D-0206-2026Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15.; Lot #: A352318912 containers75834-170-01, 75834-170-02, 75834-170-15
D-0207-2026Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03.; Lot #: A092421, Exp. Date 7/27, A092340, Exp. Date 10/26 & A092346, Exp. Date 11/26.7944 containers67777-407-01, 67777-407-02, 67777-407-03, 67777-407-10, 67777-407-04, 67777-407-11, 67777-407-12, 67777-407-13
D-0208-2026Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01.; Lot #: A35240513536 containers75834-170-01, 75834-170-02, 75834-170-15
D-0209-2026Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02.; Lot #: A3525057920 bottles75834-170-01, 75834-170-02, 75834-170-15
D-0210-2026Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.; Lot #: A47240812150 bottles69396-087-01, 69396-087-55
D-0211-2026Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.; Lot #: A47241814700 bottles69396-087-01, 69396-087-55
D-0212-2026Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02.; Lot #: A502404, Exp. Date 2/27; A502405, Exp. Date 2/27; AS02502, Exp. Date 2/28.33000 containers69396-086-02
D-0213-2026Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.; Lot #: A4823052400 containers67777-234-02, 67777-234-01, 67777-234-04, 67777-234-03
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product

    Verify if your Globe Zinc Oxide Ointment matches the recalled lot numbers (A502404, A502405, AS02502) and expiration dates (2/27 or 2/28).

  2. Contact Distributor

    Reach out to Trifecta Pharmaceuticals USA for further instructions on the remedy, as specific return or disposal steps are not provided in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: Oct 31, 202512. FDA classified it Class II: Dec 2, 202523. Published in FDA’s Enforcement Report: Dec 10, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0212-2026 (October 31, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0212-2026 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA